Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: A positron emission tomography study

Neurology

Volumn 48, Issue 4, 1997, Pages 1053-1056

  Shinotoh, H ^a   Snow, B J ^a   Chu, N S ^b   Huang, C C ^b   Lu, C S ^b   Lee, C ^a   Takahashi, H ^a   Calne, D B ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CARBON 11; MANGANESE; RACLOPRIDE;

ADULT; AKINESIA; ARTICLE; CASE REPORT; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PUTAMEN;

EID: 0030960663     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.4.1053     Document Type: Article

References (17)

1. Cotzias GC. Manganese in health and disease. Physiol Rev 1958;38:503-532.
2. Barbeau A. Manganese and extrapyramidal disorders: a critical review and tribute to Dr. George C. Cotzias. Neurotoxicology 1984;5:13-36.
3. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994;44:1583-1586.
4. Lu CS, Huang CC, Chu NS, Calne DB. Levodopa failure in chronic manganism. Neurology 1994;44:1600-1602.
5. Martin WRW, Palmer MR, Patlak CS, Calne DB. Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 1989;26:535-542.
6. 18F]fluorodopa studies correlate with dopamine cell counts and levels. Ann Neurol 1993;34:324-330.
7. Wolters EC, Huang CC, Clark C, et al. Positron emission tomography in manganese intoxication. Ann Neurol 1989;26: 674-651.
8. Farde L, Ehrin E, Eriksson L, et al. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 1985;82:3863-3867.
9. Huang CC, Lu CS, Chu NS, et al. Progression after chronic manganese exposure. Neurology 1993;43:1479-1483.
10. Duvoisin RC. The evaluation of extrapyramidal disease. In: de Ajuriagerra J, ed. Monoamines, nyaux gris centraux et syndrome de Parkinson. Paris: Masson, 1970:313-325.
11. 18F]6-fluorodopa input function: a simplified method. J Cereb Blood Flow Metab 1992;12:881-884.
12. 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184-192.
13. Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Indust Med 1993;50:510-513.
14. Shinotoh H, Snow BJ, Hewitt KA, et al. MRI and PET studies of manganese-intoxicated monkeys. Neurology 1995;45:1199-1204.
15. Eriksson H, Tedroff J, Thuomas KA, et al. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch Toxicol 1992;66:403-407.
16. Yamada M, Ohno S, Okayasu I, et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol (Berl) 1986;70:273-278.
17. Olanow CW, Good PF, Shinotoh H, et al. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 1996;46:492-498.